Labcorp Holdings (LH) Cost of Revenue (2009 - 2026)

Labcorp Holdings has reported Cost of Revenue for 18 years, with the latest figure at $2.5 billion in Q1 2026.

• Quarterly Cost of Revenue rose 5.29% year-over-year to $2.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.1 billion (up 5.93% YoY) and the FY2025 annual result came in at $9.9 billion, up 5.91% from the prior year.
• Cost of Revenue held at $2.5 billion in Q1 2026 per LH's latest filing, from $2.5 billion in the prior quarter.
• Over five years, Cost of Revenue peaked at $2.7 billion in Q1 2022 and troughed at $2.0 billion in Q2 2022.
• A 5-year average of $2.3 billion and a median of $2.3 billion in 2024 frame the typical range for Cost of Revenue.
• The widest YoY moves for Cost of Revenue: up 549.48% in 2022, down 26.02% in 2022.
• Over 5 years, Cost of Revenue stood at $2.1 billion in 2022, then climbed by 3.77% to $2.2 billion in 2023, then rose by 10.0% to $2.4 billion in 2024, then climbed by 3.68% to $2.5 billion in 2025, then gained by 0.05% to $2.5 billion in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $2.5 billion, $2.5 billion, and $2.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.